Manufacturers Life Insurance Company, The Atea Pharmaceuticals, Inc. Transaction History

Manufacturers Life Insurance Company, The

$109 Billion
Q4 2024

A detailed history of Manufacturers Life Insurance Company, The transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 32,341 shares of AVIR stock, worth $101,874. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,341

Previous 33,554 3.62%

Holding current value

$101,874

Previous $112,000 3.57%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$2.93 - $3.82 $3,554 - $4,633	-1,213 Reduced 3.62%	32,341 $108,000
Q3 2024 Nov 13, 2024	SELL	$3.17 - $4.02 $4,222 - $5,354	-1,332 Reduced 3.82%	33,554 $112,000
Q2 2024 Aug 14, 2024	BUY	$3.31 - $4.04 $14,362 - $17,529	4,339 Added 14.2%	34,886 $115,000
Q1 2024 May 14, 2024	SELL	$3.09 - $4.56 $7,533 - $11,117	-2,438 Reduced 7.39%	30,547 $123,000
Q3 2023 Nov 15, 2023	BUY	$3.0 - $3.79 $138 - $174	46 Added 0.14%	32,985 $98,000
Q2 2023 Aug 11, 2023	SELL	$3.21 - $5.06 $600,809 - $947,070	-187,168 Reduced 85.04%	32,939 $123,000
Q1 2023 May 15, 2023	SELL	$3.0 - $4.97 $569,100 - $942,809	-189,700 Reduced 86.19%	30,407 $101,000
Q4 2022 Aug 11, 2023	BUY	$4.35 - $6.17 $1,348 - $1,912	310 Added 0.14%	220,107 $1.06 Million
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.17 $1,348 - $1,912	310 Added 0.14%	220,107 $1.06 Million
Q3 2022 Aug 11, 2023	SELL	$5.49 - $8.79 $2,805 - $4,491	-511 Reduced 0.23%	219,797 $1.25 Million
Q3 2022 Nov 03, 2022	SELL	$5.49 - $8.79 $2,805 - $4,491	-511 Reduced 0.23%	219,797 $1.25 Million
Q2 2022 Aug 11, 2023	SELL	$5.33 - $8.18 $204,389 - $313,678	-38,347 Reduced 14.83%	220,308 $1.56 Million
Q2 2022 Aug 15, 2022	SELL	$5.33 - $8.18 $204,389 - $313,678	-38,347 Reduced 14.83%	220,308 $1.56 Million
Q1 2022 Aug 11, 2023	BUY	$5.5 - $9.19 $1.26 Million - $2.1 Million	228,248 Added 750.64%	258,655 $1.87 Million
Q1 2022 May 20, 2022	BUY	$5.5 - $9.19 $192,500 - $321,650	35,000 Added 15.65%	258,655 $1.86 Million
Q4 2021 Feb 16, 2022	SELL	$7.67 - $44.59 $458,420 - $2.67 Million	-59,768 Reduced 21.09%	223,655 $2.01 Million
Q3 2021 Nov 12, 2021	SELL	$21.33 - $35.06 $72,884 - $119,800	-3,417 Reduced 1.19%	283,423 $9.94 Million
Q2 2021 Aug 12, 2021	BUY	$19.22 - $59.08 $525,936 - $1.62 Million	27,364 Added 10.55%	286,840 $6.16 Million
Q1 2021 May 03, 2021	BUY	$41.42 - $88.44 $49,331 - $105,332	1,191 Added 0.46%	259,476 $16 Million
Q4 2020 Feb 12, 2021	BUY	$26.36 - $41.78 $6.81 Million - $10.8 Million	258,285 New	258,285 $10.8 Million

Others Institutions Holding AVIR

# of Institutions

112

Shares Held

50.9M

Call Options Held

900

Put Options Held

63K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $262M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Manufacturers Life Insurance Company, The, based on Form 13F filings with the SEC.

News

Stay updated on Manufacturers Life Insurance Company, The with notifications on news.

Account

Manufacturers Life Insurance Company, The Atea Pharmaceuticals, Inc. Transaction History